These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

900 related items for PubMed ID: 8102970

  • 1. Differential effects of chronic dopamine D1 and D2 receptor agonists on rotational behavior and dopamine receptor binding.
    Engber TM, Marin C, Susel Z, Chase TN.
    Eur J Pharmacol; 1993 Jun 04; 236(3):385-93. PubMed ID: 8102970
    [Abstract] [Full Text] [Related]

  • 2. N-methyl-D-aspartate receptor blockade differentially modifies regional cerebral metabolic responses to D1 and D2 dopamine agonists in rats with a unilateral 6-hydroxydopamine lesion.
    Engber TM, Anderson JJ, Boldry RC, Kuo S, Chase TN.
    Neuroscience; 1993 Jun 04; 54(4):1051-61. PubMed ID: 8101981
    [Abstract] [Full Text] [Related]

  • 3. Effects of D1 and D2 dopamine receptor stimulation on the activity of substantia nigra pars reticulata neurons in 6-hydroxydopamine lesioned rats: D1/D2 coactivation induces potentiated responses.
    Weick BG, Walters JR.
    Brain Res; 1987 Mar 10; 405(2):234-46. PubMed ID: 2952219
    [Abstract] [Full Text] [Related]

  • 4. Repeated stimulation of D1 dopamine receptors causes time-dependent alterations in the sensitivity of both D1 and D2 dopamine receptors within the rat striatum.
    Hu XT, Brooderson RJ, White FJ.
    Neuroscience; 1992 Sep 10; 50(1):137-47. PubMed ID: 1357592
    [Abstract] [Full Text] [Related]

  • 5. Dopamine supersensitivity and D1/D2 synergism are unrelated to changes in striatal receptor density.
    LaHoste GJ, Marshall JF.
    Synapse; 1992 Sep 10; 12(1):14-26. PubMed ID: 1357762
    [Abstract] [Full Text] [Related]

  • 6. Repeated D1 dopamine receptor agonist administration prevents the development of both D1 and D2 striatal receptor supersensitivity following denervation.
    Hu XT, White FJ.
    Synapse; 1992 Mar 10; 10(3):206-16. PubMed ID: 1532677
    [Abstract] [Full Text] [Related]

  • 7. Dopaminergic modulation of striatal neuropeptides: differential effects of D1 and D2 receptor stimulation on somatostatin, neuropeptide Y, neurotensin, dynorphin and enkephalin.
    Engber TM, Boldry RC, Kuo S, Chase TN.
    Brain Res; 1992 May 29; 581(2):261-8. PubMed ID: 1356580
    [Abstract] [Full Text] [Related]

  • 8. Nigral D1 and striatal D2 receptors mediate the behavioral effects of dopamine agonists.
    LaHoste GJ, Marshall JF.
    Behav Brain Res; 1990 May 28; 38(3):233-42. PubMed ID: 1973041
    [Abstract] [Full Text] [Related]

  • 9. Effects of chronic treatment with selective agonists on the subtypes of dopamine receptors.
    Subramaniam S, Lucki I, McGonigle P.
    Brain Res; 1992 Feb 07; 571(2):313-22. PubMed ID: 1351781
    [Abstract] [Full Text] [Related]

  • 10. Priming of a D1 dopamine receptor behavioural response is dissociated from striatal immediate-early gene activity.
    Paul ML, Currie RW, Robertson HA.
    Neuroscience; 1995 May 07; 66(2):347-59. PubMed ID: 7477877
    [Abstract] [Full Text] [Related]

  • 11. Differential regulation of release of acetylcholine in the striatum in mice following continuous exposure to selective D1 and D2 dopaminergic agonists.
    Wang HY, Zhou LW, Friedman E, Weiss B.
    Neuropharmacology; 1993 Jan 07; 32(1):85-91. PubMed ID: 8094235
    [Abstract] [Full Text] [Related]

  • 12. Reevaluation of the two-component hypothesis for turning behaviour by manipulating activities in the striatum and the nucleus accumbens of intact rats.
    Saigusa T, Koshikawa N, Kitamura M, Kobayashi M.
    Eur J Pharmacol; 1993 Jun 24; 237(2-3):161-8. PubMed ID: 8103458
    [Abstract] [Full Text] [Related]

  • 13. 6-hydroxydopamine treatments enhance behavioral responses to intracerebral microinjection of D1- and D2-dopamine agonists into nucleus accumbens and striatum without changing dopamine antagonist binding.
    Breese GR, Duncan GE, Napier TC, Bondy SC, Iorio LC, Mueller RA.
    J Pharmacol Exp Ther; 1987 Jan 24; 240(1):167-76. PubMed ID: 3100767
    [Abstract] [Full Text] [Related]

  • 14. Prior D1 dopamine receptor stimulation is required to prime D2-mediated striatal Fos expression in 6-hydroxydopamine-lesioned rats.
    Pollack AE, Yates TM.
    Neuroscience; 1999 Jan 24; 94(2):505-14. PubMed ID: 10579212
    [Abstract] [Full Text] [Related]

  • 15. Pressure reversed extracellular striatal dopamine decrease produced by D1 receptor agonist SKF 38393, and D2 receptor agonist LY 171555, but failed to change the effect of the activation of both D1 and D2 receptors.
    Abraini JH, Fechtali T, Rostain JC.
    Neuroscience; 1992 Sep 24; 50(2):395-402. PubMed ID: 1359460
    [Abstract] [Full Text] [Related]

  • 16. Striatal Fos expression is indicative of dopamine D1/D2 synergism and receptor supersensitivity.
    LaHoste GJ, Yu J, Marshall JF.
    Proc Natl Acad Sci U S A; 1993 Aug 15; 90(16):7451-5. PubMed ID: 8102797
    [Abstract] [Full Text] [Related]

  • 17. D1-like and D2-like dopamine receptors synergistically activate rotation and c-fos expression in the dopamine-depleted striatum in a rat model of Parkinson's disease.
    Paul ML, Graybiel AM, David JC, Robertson HA.
    J Neurosci; 1992 Oct 15; 12(10):3729-42. PubMed ID: 1357113
    [Abstract] [Full Text] [Related]

  • 18. Differential effects of quinpirole in the nucleus accumbens depending on the initial level of locomotor activity.
    Wu M, Brudzynski SM, Mogenson GJ.
    Brain Res Bull; 1993 Oct 15; 32(4):395-8. PubMed ID: 8106125
    [Abstract] [Full Text] [Related]

  • 19. D1 dopamine receptor stimulation enables the postsynaptic, but not autoreceptor, effects of D2 dopamine agonists in nigrostriatal and mesoaccumbens dopamine systems.
    Wachtel SR, Hu XT, Galloway MP, White FJ.
    Synapse; 1989 Oct 15; 4(4):327-46. PubMed ID: 2532422
    [Abstract] [Full Text] [Related]

  • 20. Lesions of the nigrostriatal dopamine projection increase the inhibitory effects of D1 and D2 dopamine agonists on caudate-putamen neurons and relieve D2 receptors from the necessity of D1 receptor stimulation.
    Hu XT, Wachtel SR, Galloway MP, White FJ.
    J Neurosci; 1990 Jul 15; 10(7):2318-29. PubMed ID: 1973947
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 45.